Abstract
Electronic health record (EHR) systems with prescription data offer vast potential in pharmacoepidemiology and pharmacogenomics. The large amount of clinical data recorded in these systems requires automatic processing to extract relevant information. This paper introduces PRESNER, a name entity recognition (NER) and classification pipeline for EHR prescription data.
The pipeline uses the pre-trained transformer Bio-ClinicalBERT fine-tuned on UK Biobank prescription entries manually annotated with medication-related information (drug name, route of administration, pharmaceutical form, strength, and dosage) as the core NER system. Moreover, PRESNER also maps drugs to the Anatomical Therapeutic and Chemical (ATC) classification system and distinguishes between systemic and non-systemic drug products. It outperformed a baseline model combining the state-of-the-art Med7 and a dictionary-based approach from the ChEMBL database with a macro-average F1-score of 0.95 vs 0.71. In addition to UK Biobank prescription data, PRESNER can also be applied to other English prescription datasets, making it a versatile tool for researchers in the field.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Novo Nordisk Foundation (NNF17OC0027594).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used available human data that were originally located at the UK Biobank resource.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
UK Biobank data are available under restricted access through a procedure described at http://www.ukbiobank.ac.uk/using-the-resource/. All other data produced in the present work and the code are available at https://github.com/ccolonruiz/PRESNER
